Mobile

A Phase 1 Study To Evaluate The Pharmacokinetics And Safety Of Three Modified Release And One Immediate Release Formulations Of Tofacitinib (CP-690,550) In Healthy Volunteers

Mise à jour : Il y a 4 ans
Référence : NCT01499004

Femme et Homme

  • | Pays :
  • Singapore
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

This study will explore the drug behavior and safety following a single dose of three different 22 milligram tofacitinib (CP-690,550) modified-release formulations in 30 healthy volunteers. These formulations will be compared to 10 milligram tofacitinib (CP-690-550) in an immediate-release formulation.

Critère d'inclusion

  • Healthy

Liens